Drug Enforcement D-0609-2025

Subpotent Drug

Status

Ongoing

Classification

Class II

Report Date

September 10, 2025

Termination Date

—

Product Information

Product description
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Product quantity
648 vials
Reason for recall
Subpotent Drug
Recall initiation reason
—
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
U.S. Nationwide

Location & Firm

Recalling firm
Boothwyn Pharmacy LLC
Address
221 Gale Ln, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0609-2025
Event ID
97202
Recall initiation date
July 9, 2025
Center classification date
August 29, 2025
Code info
03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025
More code info
—